Eyenovia to Report Third Quarter 2021 Results on Thursday, November 11

Company to host an investor conference call and webcast at 5:00pm ET on that day

NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) —

Eyenovia, Inc.

(NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, announced that the Company will release financial results for the third quarter ended September 30, 2021 on Thursday, November 11, 2021, after the market close. Following the release, Eyenovia management will host a conference call to review the financial and operating results and provide a business update.

The conference call is scheduled to begin at 5:00pm ET on Thursday, November 11, 2021. Participants should dial 877-407-9039 (domestic) or 201-689-8470 (international) with the conference code 13724626. A live webcast of the conference call will also be available on the investor relations page of the Company’s corporate website at

www.eyenovia.com

.

After the live webcast, the event will be archived on Eyenovia’s website for one year.


About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit

www.eyenovia.com

.

The Eyenovia Corporate Information slide deck may be found at

ir.eyenovia.com/events-and-presentations

.


Eyenovia Contact:


Eyenovia, Inc.

John Gandolfo

Chief Financial Officer



[email protected]


Eyenovia Investor Contact:


Eric Ribner

LifeSci Advisors, LLC



[email protected]



(646) 751-4363


Eyenovia Media Contact:


Sam Choinski

Pazanga Health Communications


[email protected]


(603) 489-5964



Primary Logo